YouTube as a potential source of information on deep venous thrombosis

2016 ◽  
Vol 32 (8) ◽  
pp. 543-547 ◽  
Author(s):  
Mehmet Ş Bademci ◽  
Serkan Yazman ◽  
Tevfik Güneş ◽  
Gokhan Ocakoglu ◽  
Kaptanderya Tayfur ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Treatment Modalities ◽  
Medical Professionals ◽  
Scientific Content ◽  
Exclusion Criteria ◽  
Vein Thrombosis ◽  
Potential Source ◽  
Scientific Accuracy ◽  
Deep Vein ◽  
Source Of Information

Background No work has been reported on the use of video websites to learn about deep vein thrombosis and the value of education using them. We examined the characteristics and scientific accuracy of videos related to deep vein thrombosis on YouTube. Methods YouTube was surveyed using no filter and the key words ‘deep vein thrombosis’ and ‘leg vein clot’ in June 2016. The videos evaluated were divided into three groups in terms of their scientific content, accuracy, and currency: useful, partly useful, and useless. Results Of the 1200 videos watched, 715 (59.58%) were excluded with the exclusion criteria. Although most of the videos uploaded (22.9%, n = 111) were created by physicians, the number of views for website-based videos was significantly higher (p = 0.002). When the uploaded videos were assessed in terms of their usefulness, videos from physicians and hospitals were statistically more useful than other videos (p < 0.001). Conclusions For videos created by medical professionals to be of higher quality, we believe they should be more up-to-date and comprehensive, and contain animations about treatment modalities and early diagnosis in particular.

scholarly journals Breast cancer presenting as subclavian/axillary deep vein thrombosis and upper limb lymphoedema

2012 ◽  
Vol 94 (2) ◽  
pp. e55-e56 ◽  
Author(s):  
SJ Kruger
Keyword(s):  
Breast Cancer ◽  
Deep Vein Thrombosis ◽  
Inflammatory Breast Cancer ◽  
Delayed Diagnosis ◽  
Rare Condition ◽  
Treatment Modalities ◽  
Vein Thrombosis ◽  
Relationship Of ◽  
Deep Vein ◽  
The Relationship

This case report describes the delayed diagnosis of inflammatory breast cancer following initial presentation with a subclavian/axillary deep vein thrombus. The relationship of thrombosis and cancer is discussed and the typical presentation of inflammatory breast cancer described. Understanding the relationship between thromboembolism and cancer is crucial to support the early diagnosis of breast cancer, which can present insidiously. The literature is reviewed, highlighting the improving prognosis of this rare condition and the current preferred treatment modalities.

Percutaneous pharmacomechanical thrombectomy for acute iliofemoral deep vein thrombosis: A suitability study

2014 ◽  
Vol 30 (4) ◽  
pp. 235-241 ◽  
Author(s):  
AZ Nghiem ◽  
N Rudarakanchana ◽  
HM Moore ◽  
AH Davies
Keyword(s):  
Deep Vein Thrombosis ◽  
Lower Limb ◽  
Randomised Trial ◽  
Duplex Ultrasound ◽  
Exclusion Criteria ◽  
Vein Thrombosis ◽  
Acute Deep Vein Thrombosis ◽  
Deep Vein ◽  
Limb Deep Vein Thrombosis

Objectives Percutaneous pharmacomechanical thrombectomy is an emerging therapy for acute deep vein thrombosis and may reduce long-term incidence of post-thrombotic syndrome. This study investigates the proportion of patients presenting with lower limb deep vein thrombosis who are potentially suitable for percutaneous pharmacomechanical thrombectomy. Methods A retrospective review of all duplex ultrasound scans for lower limb deep vein thrombosis over two-year period at a regional vascular unit was conducted. All acute occlusive iliofemoral deep vein thrombosis were screened for percutaneous pharmacomechanical thrombectomy suitability according to predefined criteria. Results There were 2513 duplex ultrasound scans for suspected lower limb deep vein thrombosis in the two-year period. There were 120 cases of acute occlusive iliofemoral deep vein thrombosis. After application of inclusion and exclusion criteria 48 out of 120 (40%) patients were identified as potential candidates for percutaneous pharmacomechanical thrombectomy. Conclusions This indicates that a large randomised trial of percutaneous pharmacomechanical thrombectomy is feasible given expected recruitment rates in a multicentre study.

scholarly journals Screening and Risk Factor Associated with Deep Vein Thrombosis among Factory Workers

2021 ◽  
pp. 253-258
Author(s):  
Monali Walke ◽  
Savita Pohekar
Keyword(s):  
Risk Factor ◽  
Deep Vein Thrombosis ◽  
Research Study ◽  
Structure Questionnaire ◽  
Factory Workers ◽  
Exclusion Criteria ◽  
Vein Thrombosis ◽  
Steel Factory ◽  
Mechanical Methods ◽  
Deep Vein

Background: Venous thrombo embolism (VTE) its a form of vascular disorder becomes important disease condition now a days. Basically VTE is term used for both deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT is defined as a blood clot (thrombus) in a deep vein usually in the legs, also in the calf and thigh veins. It is 3rd largest cause for mortality and morbidity. Deep vein thrombosis occur mostly there are no symptoms but in some cases lower extremity will be painful, warm redden, and also superficial veins may engorged. In such cases when there is massive embolism thrombolytic therapy agent as streptokinase or urokinase or tissue plasminogen activation used for dissolve the thrombus or resolve the obstruction. For relieving chances of venous thrombosis like range of motion, physiotherapy, graduated stocking can be categorized as important mechanical methods for the prevention of DVT. Objective: In this study 1. To Screen   the deep vein thrombosis among factory workers To assess the risk factor of deep vein thrombosis among factory workers To associate the screening and risk factor of deep vein thrombosis among factory workers with their selected demographic variables Methodology: Descriptive research design will use for this research study. Sample will be factory workers. Non probability purposive sampling technique will use for the study. This research study will include 120 Factory workers from Mahalakshmi Steel factory Pvt. Ltd, Deoli, Dist.Wardha, Maharashtra. Factory workers must select according to requirements for inclusion and exclusion criteria. 1.Factory workers who were   completed   5 years   in steel   factory & Factory workers who are willing participate in study are inclusion criteria. Exclusion Criteria: 1.Factory workers who   already taking treatment for deep vein thrombosis. 2. Factory workers those were participated in similar kind of study. 3. Office workers are excluded in this study. Expected Results: Outcome includes Screening and risk factors associated with deep vein thrombosis among factory workers for the study are low probability, moderate probability, high probability with the clinical validated tool Wells criteria for screening of deep vein thrombosis. Risk factor associated with deep vein thrombosis assess with structure questionnaire. Ethical approval was obtained from (DMIMS(DU)/IEC/DEC-2019/8684).  Conclusion: It will be drawn from the results.

scholarly journals Expert Consensus on the Contraindications and Cautions of Foam Rolling—An International Delphi Study

2021 ◽  
Vol 10 (22) ◽  
pp. 5360
Author(s):  
Katja Martina Bartsch ◽  
Christian Baumgart ◽  
Jürgen Freiwald ◽  
Jan Wilke ◽  
Gunda Slomka ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Delphi Study ◽  
Bone Fractures ◽  
Methodological Approach ◽  
A Priori ◽  
Delphi Process ◽  
Medical Professionals ◽  
Foam Rolling ◽  
Vein Thrombosis ◽  
Deep Vein

Background: Foam rolling is a type of self-massage using tools such as foam or roller sticks. However, to date, there is no consensus on contraindications and cautions of foam rolling. A methodological approach to narrow that research gap is to obtain reliable opinions of expert groups. The aim of the study was to develop experts’ consensus on contraindications and cautions of foam rolling by means of a Delphi process. Methods: An international three-round Delphi study was conducted. Academic experts, defined as having (co-) authored at least one PubMed-listed paper on foam rolling, were invited to participate. Rounds 1 and 2 involved generation and rating of a list of possible contraindications and cautions of foam rolling. In round 3, participants indicated their agreement on contraindications and cautions for a final set of conditions. Consensus was evaluated using a priori defined criteria. Consensus on contraindications and cautions was considered as reached if more than 70% of participating experts labeled the respective item as contraindication and contraindication or caution, respectively, in round 3. Results: In the final Delphi process round, responses were received from 37 participants. Panel participants were predominantly sports scientists (n = 21), physiotherapists (n = 6), and medical professionals (n = 5). Consensus on contraindications was reached for open wounds (73% agreement) and bone fractures (84%). Consensus on cautions was achieved for local tissue inflammation (97%), deep vein thrombosis (97%), osteomyelitis (94%), and myositis ossificans (92%). The highest impact/severity of an adverse event caused by contraindication/cautions was estimated for bone fractures, deep vein thrombosis, and osteomyelitis. Discussion: The mechanical forces applied through foam rolling can be considered as potential threats leading to adverse events in the context of the identified contraindications and cautions. Further evaluations by medical professionals as well as the collection of clinical data are needed to assess the risks of foam rolling and to generate guidance for different applications and professional backgrounds.

Comparison of Direct Iliofemoral Stenting Following AngioJet Rheolytic Thrombectomy vs Staged Stenting After AngioJet Rheolytic Thrombectomy Plus Catheter-Directed Thrombolysis in Patients With Acute Deep Vein Thrombosis

2017 ◽  
Vol 25 (1) ◽  
pp. 133-139 ◽  
Author(s):  
Guang Liu ◽  
Jinbao Qin ◽  
Chaoyi Cui ◽  
Kaichuang Ye ◽  
Huihua Shi ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Hospital Stay ◽  
Length Of Hospital Stay ◽  
Treatment Modalities ◽  
Similar Treatment ◽  
Vein Thrombosis ◽  
Catheter Directed Thrombolysis ◽  
Direct Stenting ◽  
Rheolytic Thrombectomy ◽  
Deep Vein

Purpose: To compare the treatment outcomes in patients with acute proximal deep vein thrombosis (DVT) and iliofemoral stenosis who underwent either direct stenting after AngioJet rheolytic thrombectomy or staged stenting after AngioJet thrombectomy plus catheter-directed thrombolysis with urokinase. Methods: From June 2014 to February 2016, 91 DVT patients underwent 2 treatments for duplex-verified iliofemoral stenosis: direct stenting (n = 46; mean age 54.8 years; 32 men) or staged stenting (n = 45; mean age 56.5 years; 27 men). The degree of patency after thrombectomy or thrombolysis was evaluated using the Venous Registry Index (VRI), while the risk of postthrombotic syndrome (PTS) was evaluated according to the Villalta scale. Patients were followed with periodic duplex ultrasound scans up to 1 year. Results: The technical success rates were 100% in both groups; there was no 30-day mortality. Immediate (24-hour) clinical improvement was achieved in 42 (91%) of 46 direct group patients vs 33 (73%) of 45 staged group patients (p<0.001). A significant reduction (p<0.001) in the length of hospital stay was noted in the direct group (4.59±0.91) compared with that in the staged group (5.8±1.6). The stents used in the direct group were longer but with similar diameter compared with the staged group. The thrombolysis rates were 81.50%±5.76% in the direct group and 85.67%±3.84% in the staged group (p<0.001). The VRIs declined (improved) significantly in both groups (11.68±1.92 to 3.21±1.44 in the direct group and 12.17±2.29 to 2.36±1.19 in the staged group, both p<0.001). The Villalta scores were significantly better in the staged group (p<0.001). Recurrent DVT occurred in 2 patients in the direct group. The primary patency rates at 1 year were 93.5% in the direct group and 97.8% in the staged group (p=0.323). Conclusion: Both direct and staged stenting are effective treatment modalities for patients with acute proximal DVT. Compared with staged stenting, direct stenting provides similar treatment success and a significant reduction in the length of hospital stay; however, it has lower thrombolysis efficacy, and the risk of PTS at 1 year is greater with direct stenting.

Feasibility Study of Catheter-directed Thrombolysis with Recombinant Staphylokinase in Deep Venous Thrombosis

1998 ◽  
Vol 79 (03) ◽  
pp. 517-519 ◽  
Author(s):  
Stephane Heymans ◽  
Raymond Verhaeghe ◽  
Luc Stockx ◽  
Désiré Collen
Keyword(s):  
Deep Vein Thrombosis ◽  
Continuous Infusion ◽  
High Speed ◽  
Minor Bleeding ◽  
Vein Thrombosis ◽  
Catheter Directed Thrombolysis ◽  
Long Term Follow Up ◽  
Valve Function ◽  
Rotating Impeller ◽  
Deep Vein

SummaryThe feasibility of catheter-directed thrombolysis with recombinant staphylokinase was evaluated in six selected patients with deep vein thrombosis. The patients underwent intrathrombus infusion of recombinant staphylokinase (2 mg bolus followed by a continuous infusion of 1 mg/h). Heparin was given via the catheter as a bolus (5000 U) and as a continuous infusion (1000 U/h). Complete lyis was obtained in five patients and partial lysis in one patient. Complications consisted of minor bleeding in four subjects. Symptomatic reocclusion occurred in one. Debulking of the thrombus mass by a high speed rotating impeller (n = 1) and stenting (n = 3) were used as additional interventions. An underlying anatomical abnormality was present in two patients. Long term follow up revealed normal patency in all patients and normal valve function in four patients. Symptomatic venous insufficiency with valve dysfunction was present in the two with a second thrombotic episode.Thus catheter-directed infusion of recombinant staphylokinase in patients with deep vein thrombosis appears feasible and may be associated with a high frequency of thrombolysis. Larger studies to define the clinical benefit of this treatment appear to be warranted.

Deep Vein Thrombosis and Fibrinolysis

1991 ◽  
Vol 66 (04) ◽  
pp. 426-429 ◽  
Author(s):  
Marcel Levi ◽  
Anthonie W A Lensing ◽  
Harry R Büller ◽  
Paolo Prandoni ◽  
Gerard Dooijewaard ◽  
...  
Keyword(s):  
Deep Vein Thrombosis ◽  
Plasminogen Activator ◽  
Plasminogen Activator Inhibitor ◽  
Tissue Type ◽  
Controlled Study ◽  
First Episode ◽  
Control Group ◽  
Vein Thrombosis ◽  
Type Plasminogen Activator ◽  
Deep Vein

SummaryIn the present study 57 consecutive patients with a first episode of venographically proven deep vein thrombosis were investigated to evaluate the release of tissue-type plasminogen activator (t-PA) and of urokinase-type plasminogen activator (u-PA) in response to DDAVP stimulation as well as the resting plasminogen activator inhibitor (PAI) concentration, comparing this to the results obtained in 66 similar patients with a clinical suspicion of thrombosis but with a normal venogram. All assays were performed without knowledge of the patient's status.Four patients in the deep vein thrombosis-group (7%) had an absent u-PA antigen response upon DDAVP infusion, while a normal response was observed in all control subjects. Patients and controls showed similar increases in t-PA antigen level upon DDAVP. High resting PAI antigen levels were encountered in 5 patients in the deep vein thrombosis-group (9%) and in 6 subjects in the control group (9%).The results from this controlled study indicate that a defective release of u-PA may occur in patients with deep vein thrombosis and may have pathogenetic significance. Furthermore it is concluded that elevation of PAI levels cannot be considered as a specific risk factor for venous thrombosis.

Sign in / Sign up

Export Citation Format

Share Document